Overview


The Term Respiratory Diseases Testing is used to describe the process of diagnosing various respiratory diseases through physical examinations. The test can help diagnose lung conditions and measure how quickly the lungs can expel air. This can be helpful to a clinician even before the patient experiences symptoms. Respiratory disease tests are mainly used to detect and diagnose respiratory conditions early, which allows for earlier treatment. In recent years, the use of artificial intelligence (AI) has increased significantly in many fields of medicine. The main reason for this is the advancement of high-performance computing and the development of deep learning (DL), a set of AI algorithms that uses neural networks to solve specific problems from expert-labeled databases.

Medical Imaging is one field that has experienced a paradigm change due to AI. Traditional image processing algorithms, including filtering, shadowing, and geometric atlas have not been able to solve complex problems such as the high-accuracy identification of lung fissures using computed tomography. Convolutional neural network (CNN) is a type of DL algorithm that uses databases of labeled pictures to learn convolutional filtering. This has dramatically changed the scenario in recent years. These filters can extract several imaging features, which when combined sequentially, allow the interpretation of complex patterns such as those found in medical images. The principles of AI and their applications for pulmonary specialists will enable them to take advantage of future research and practice opportunities.

FutureWise Market Research has instantiated a report that provides an intricate analysis of AI in Respiratory Diseases Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the AI in Respiratory Diseases Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • Simenes Healthineers
  • VIDA Diagnostics Inc
  • THIRONA
  • Infervision
  • icometrix

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Indication

  • Chronic Obstructive Pulmonary Disease
  • Interstitial Lung Disease
  • Pulmonary Infection

By Imaging Type

  • MRI
  • CT Scan
  • ePRO

By End-use

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgical centers
  • Others

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the AI in Respiratory Diseases Market By Indication, By Imaging Type, By End-use, and By Region
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape, mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.  Market Introduction
    •   1. Objectives of the Study 
        2. Market Definition 
        3. Market Scope 
           3.1. Years Considered for the Study
           3.2. Market Covered
        4. Currency 
        5. Limitations 
        6. Stakeholders 

  • 2.  Research Methodology
    •   1 Research Data 
           1.1. Secondary Data
              1.1.1. Key Data from Secondary Sources
           1.2 Primary Data
              1.2.1. Key Data from Primary Sources
        3.Market Size Estimation 
        4. Market Breakdown and Data Triangulation 
        5. Assumptions for the Study 

  • 3.  Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights

  • 4.  AI in Respiratory Diseases Market Variables, Trends & Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Application Overview
        6. Regulatory Framework
           6.1. Reimbursement Framework
           6.2. Standards and Compliances

  • 5.  Market Overview
    •   1. Market Dynamics
           1.1. Market Driver Analysis
              1.1.1. Increasing focus of AI in Respiratory Diseases Market Companies on Brand Protection
              1.1.2. Untapped Opportunities in Emerging Regions
           1.2. Market Restraint Analysis
              1.2.1. High Cost Associated with Implementation of Predictive Analysis
           1.3. Industry Challenges
              1.3.1. Presence of Ambiguous Regulatory Framework

  • 6.  AI in Respiratory Diseases Market Analysis Tools
    •   1. Industry Analysis - Porter’s
           1.1. Supplier Power
           1.2. Buyer Power
           1.3. Substitution Threat
           1.4. Threat from New Entrants
           1.5. Competitive Rivalry
        2. Pestel Analysis
           2.1. Political Landscape
           2.2. Environmental Landscape
           2.3. Social Landscape
           2.4. Application Landscape
           2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
           3.1. Joint Ventures
           3.2. Mergers and Acquisitions
           3.3. Licensing and Partnership
           3.4. Application Collaborations
           3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies

  • 7.  AI in Respiratory Diseases Market, By Indication Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Chronic Obstructive Pulmonary Disease
        2. Interstitial Lung Disease
        3. Pulmonary Infection

  • 8.  AI in Respiratory Diseases Market, By Imaging Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. MRI
        2. CT Scan
        3. ePRO

  • 9.  AI in Respiratory Diseases Market, By End-use Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Diagnostic Centers
        3. Ambulatory Surgical centers
        4. Others

  • 10.  North America AI in Respiratory Diseases Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. U.S.A
           2.2. Canada
           2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.  Latin America AI in Respiratory Diseases Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Brazil
           2.2. Venezuela
           2.3. Argentina
           2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.  Europe AI in Respiratory Diseases Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Germany
           2.2. U.K
           2.3. France
           2.4. Italy
           2.5. Spain
           2.6. Russia
           2.7. Poland
           2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.  Asia Pacific AI in Respiratory Diseases Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. Japan
           2.2. China
           2.3. India
           2.4. Australia and New Zealand
           2.5. ASEAN
           2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.  Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
           2.1. GCC
           2.2. Israel
           2.3. South Africa
           2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.  Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix

  • 16.  Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Simenes Healthineers
           1.1. Company Overview
           1.2. Product Portfolio
           1.3. Swot Analysis
           1.4. Financial Overview
           1.5. Strategic Overview
        2. VIDA Diagnostics Inc
           2.1. Company Overview
           2.2. Product Portfolio
           2.3. Swot Analysis
           2.4. Financial Overview
           2.5. Strategic Overview
        3. THIRONA
           3.1. Company Overview
           3.2. Product Portfolio
           3.3. Swot Analysis
           3.4. Financial Overview
           3.5. Strategic Overview
        4. Infervision
           4.1. Company Overview
           4.2. Product Portfolio
           4.3. Swot Analysis
           4.4. Financial Overview
           4.5. Strategic Overview
        5. icometrix
           5.1. Company Overview
           5.2. Product Portfolio
           5.3. Swot Analysis
           5.4. Financial Overview
           5.5. Strategic Overview

  • 17.  Pre and Post COVID-19 Impact
    •   1. Positive Influence On The Healthcare Industry
        2. The Financial Disruption Of The Manufacturing Sector
        3. Impact Of Covid-19 On Emerging Companies
        4. Significant Mandates In The Healthcare Regulations Initiated
      By Administrations
        5. The Overall Economic Slowdown Of The Developing And Developed Nations

  • 18.  FutureWise SME Key Takeaway Points for Client
    •   

Partner

Our Clients